K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 222 JPY -0.82% Market Closed
Market Cap: 159.9B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Kaken Pharmaceutical Co Ltd stock under the Base Case scenario is 1 868.65 JPY. Compared to the current market price of 4 222 JPY, Kaken Pharmaceutical Co Ltd is Overvalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
1 868.65 JPY
Overvaluation 56%
Intrinsic Value
Price
K
Worst Case
Base Case
Best Case

Valuation History
Kaken Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Kaken Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Kaken Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

4 222 JPY
-0.82%
-0.82%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Kaken Pharmaceutical Co Ltd
JP
Pharmaceuticals
Market Cap
159.9B JPY
IPO
Oct 2, 1961
Employees
1 215
Japan
Market Cap
159.9B JPY
Industry
Pharmaceuticals
IPO
Oct 2, 1961
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Kaken Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Kaken Pharmaceutical Co Ltd.

What unique competitive advantages
does Kaken Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Kaken Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Kaken Pharmaceutical Co Ltd.

Provide P/S
for Kaken Pharmaceutical Co Ltd.

Provide P/E
for Kaken Pharmaceutical Co Ltd.

Provide P/OCF
for Kaken Pharmaceutical Co Ltd.

Provide P/FCFE
for Kaken Pharmaceutical Co Ltd.

Provide P/B
for Kaken Pharmaceutical Co Ltd.

Provide EV/S
for Kaken Pharmaceutical Co Ltd.

Provide EV/GP
for Kaken Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Kaken Pharmaceutical Co Ltd.

Provide EV/EBIT
for Kaken Pharmaceutical Co Ltd.

Provide EV/OCF
for Kaken Pharmaceutical Co Ltd.

Provide EV/FCFF
for Kaken Pharmaceutical Co Ltd.

Provide EV/IC
for Kaken Pharmaceutical Co Ltd.

Show me price targets
for Kaken Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Kaken Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Kaken Pharmaceutical Co Ltd?

What are the Net Income projections
for Kaken Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Kaken Pharmaceutical Co Ltd?

What are the EPS projections
for Kaken Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Kaken Pharmaceutical Co Ltd?

What are the EBIT projections
for Kaken Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Kaken Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Kaken Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Kaken Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Kaken Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Kaken Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Kaken Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Kaken Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Kaken Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Kaken Pharmaceutical Co Ltd.

Provide ROE
for Kaken Pharmaceutical Co Ltd.

Provide ROA
for Kaken Pharmaceutical Co Ltd.

Provide ROIC
for Kaken Pharmaceutical Co Ltd.

Provide ROCE
for Kaken Pharmaceutical Co Ltd.

Provide Gross Margin
for Kaken Pharmaceutical Co Ltd.

Provide Operating Margin
for Kaken Pharmaceutical Co Ltd.

Provide Net Margin
for Kaken Pharmaceutical Co Ltd.

Provide FCF Margin
for Kaken Pharmaceutical Co Ltd.

Show all solvency ratios
for Kaken Pharmaceutical Co Ltd.

Provide D/E Ratio
for Kaken Pharmaceutical Co Ltd.

Provide D/A Ratio
for Kaken Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Kaken Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Kaken Pharmaceutical Co Ltd.

Provide Quick Ratio
for Kaken Pharmaceutical Co Ltd.

Provide Current Ratio
for Kaken Pharmaceutical Co Ltd.

Provide Cash Ratio
for Kaken Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Kaken Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Kaken Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Kaken Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Kaken Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kaken Pharmaceutical Co Ltd

Current Assets 122.7B
Cash & Short-Term Investments 84B
Receivables 21B
Other Current Assets 17.7B
Non-Current Assets 64.4B
Long-Term Investments 19.1B
PP&E 26.5B
Intangibles 7.4B
Other Non-Current Assets 11.5B
Current Liabilities 23.7B
Accounts Payable 6B
Accrued Liabilities 884m
Short-Term Debt 3.9B
Other Current Liabilities 12.9B
Non-Current Liabilities 9B
Other Non-Current Liabilities 9B
Efficiency

Earnings Waterfall
Kaken Pharmaceutical Co Ltd

Revenue
87.2B JPY
Cost of Revenue
-34.3B JPY
Gross Profit
52.9B JPY
Operating Expenses
-29.3B JPY
Operating Income
23.6B JPY
Other Expenses
-5.3B JPY
Net Income
18.2B JPY

Free Cash Flow Analysis
Kaken Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kaken Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive ROIC
57/100
Profitability
Score

Kaken Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kaken Pharmaceutical Co Ltd's solvency score is 98/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
98/100
Solvency
Score

Kaken Pharmaceutical Co Ltd's solvency score is 98/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kaken Pharmaceutical Co Ltd

Wall Street analysts forecast Kaken Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 947 JPY with a low forecast of 3 636 JPY and a high forecast of 6 405 JPY.

Lowest
Price Target
3 636 JPY
14% Downside
Average
Price Target
4 947 JPY
17% Upside
Highest
Price Target
6 405 JPY
52% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Kaken Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Kaken Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Kaken Pharmaceutical Co Ltd stock?

The intrinsic value of one Kaken Pharmaceutical Co Ltd stock under the Base Case scenario is 1 868.65 JPY.

Is Kaken Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4 222 JPY, Kaken Pharmaceutical Co Ltd is Overvalued by 56%.

Back to Top